Background: Given the domestic production of cardiac monitoring devices in the country, it is necessary for these devices to be evaluated from a scientific perspective and for the accuracy of their reports to be confirmed. Therefore, the present study was conducted with the aim of comparing the effectiveness of the Holter monitoring device manufactured by Sayran Company with the Holter device manufactured by Norva Company, Germany.
Methods: In this action research study conducted in 2021 at Al-Zahra Hospital in Isfahan, 30 patients requiring Holter monitoring underwent cardiac monitoring with the Saairan Holter device. The device's findings were evaluated in comparison with a foreign counterpart (Norva) and based on the opinions of cardiologists regarding its performance.
Findings: The mean total score (out of a maximum of 108) for the Saairan Holter monitoring device was 69.80 ± 9.32 (range: 59-91). The mean percentage score obtained was 64.63% ± 8.63%. Based on user assessments, the device's performance was rated as acceptable in 26 cases (86.7%) and excellent in 4 cases (13.3%).
Conclusion: It seems that the Holter monitoring device manufactured by Saairan Company is similar to foreign models in terms of accuracy, quality, and efficiency and can be used by cardiologists. Furthermore, given that the cost of this device is approximately one-third of the price of a similar foreign product, its purchase and use are cost-effective for both physicians and patients.